Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trial

Journal:

Cell

Published:

2026-02-11

DOI:

10.1016/j.cell.2025.12.055

Affiliations:

9

Authors:

18

Go to article

Institutions	Authors	Share
Dana-Farber Cancer Institute (DFCI), United States of America (USA)	6.166667	0.34
Mass General Brigham, United States of America (USA)	3.000000	0.17
Harvard Medical School (HMS), United States of America (USA)	2.833333	0.16
Weizmann Institute of Science (WIS), Israel	2.000000	0.11
Massachusetts General Hospital (MGH), United States of America (USA)	1.500000	0.08
Broad Institute of MIT and Harvard, United States of America (USA)	1.500000	0.08
Heidelberg Institute for Stem Cell Technologies and Experimental Medicine (HI-STEM gGmbH), Germany	0.333333	0.02
German Cancer Research Center in the Helmholtz Association (DKFZ), Germany	0.333333	0.02
Brigham and Women's Hospital (BWH), United States of America (USA)	0.333333	0.02

Interested in Oncology and Carcinogenesis?